Myriad Genetics
MYGN
#7319
Rank
ยฃ0.40 B
Marketcap
ยฃ4.17
Share price
-1.44%
Change (1 day)
-15.20%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2026 (TTM): -ยฃ1.03

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is -ยฃ1.04. In 2025 the company made an earnings per share (EPS) of -ยฃ3.01 a decrease over its 2024 EPS that were of -ยฃ1.08.

EPS history for Myriad Genetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ1.03-65.96%
2025-ยฃ3.01179.43%
2024-ยฃ1.08-55.94%
2023-ยฃ2.45130.22%
2022-ยฃ1.06275.68%
2021-ยฃ0.28-87.99%
2020-ยฃ2.35755.56%
2019-ยฃ0.28-194.74%
2018ยฃ0.29-79.89%
2017ยฃ1.44112.36%
2016ยฃ0.68-35.97%
2015ยฃ1.06-7.33%
2014ยฃ1.15-37.24%
2013ยฃ1.8359.33%
2012ยฃ1.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
ยฃ2.07-298.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-ยฃ4.07 291.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-ยฃ0.06880-93.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-ยฃ38.91 3,642.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
ยฃ29.17-2,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA